Allenex AB: XM-ONE Receives US Patent Protection

Published: Oct 13, 2011

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: AbSorber, part of Allenex (STO:ALNX) group, focusing on antibody detection before transplantation has received US patent protection for its cross match-test XM-ONE®. The patent, with the title Methods of Donor Specific Crossmatching, was granted by the US Patent and Trademark Office. AbSorber has previously approved patent for XM-ONE® in other regions including the European Union, India, Australia and Canada. “The fact that our patent was approved in the U.S. is of great value to us. It is a strong confirmation that the product is unique and has a high degree of innovation. Currently we are working hard in collaboration with leading laboratories in the U.S. to establish clinical use of the product”, said Anders Karlsson, CEO Allenex.

Back to news